Pleased to meet you, we are Galapagos, a dynamic fast growing Biotech company with offices in Europe in Belgium (Mechelen), France (Romainville & Paris), the Netherlands (Leiden), Switzerland (Basel), Italy (Milano), Spain (Madrid), the UK (London), Germany (München), and in the US (Boston).
We are in the business of changing lives. In our quest to discover and develop life-improving medicines we go where no one has ever gone before. In every challenge we face, we see new opportunities. We want to challenge the impossible. We need thought leaders and rapid thinkers, entrepreneurs in spirit and status quo-fighters. Collaborative innovators and perseverant idealists. We need the best-in-class. In other words, we need you: The ‘make-it-happeners’.
We are looking for an Head of Discovery Oncology - Mechelen,BE/Leiden,NL/Basel,CH/Romainville,FR
Scope of the funtion
You lead and manage the teams, resources and activities of the oncology discovery group reporting to the Senior Vice President, Head of Discovery small molecules. You interact closely with the commercial, licensing & acquisition and with the development organizations to set up the priorities for the oncology portfolio, while choosing the best modalities to reach these objectives. You also design the scientific and organizational strategy to deliver a portfolio of novel drug candidates in the field of oncology. Part of your responsibilities is the identification and validation of targets, pathways and animal models aligned with the selected strategic approaches. For active drug discovery projects, you operate in a matrix environment and orchestrates the activities of several departments (ranging from in vitro to in vivo pharmacology), bringing adequate disease models to mechanistically understand and progress new molecules.
You are also leading research activities for projects that entered clinical phases supporting indication selection and answering translational questions. Finally, you are expected to drive the generation of an up-to-date knowledge environment and to set up external collaborations to sharpen Galapagos’ oncology knowledge.
Who are you?